MLAB Biosciences is a biotechnology company that leverages its proprietary DIRECT™ platform to discover and develop novel antibody-based therapies for muscular dystrophies (musculoskeletal diseases) and other unmet medical needs.
MLAB Biosciences is incubated by ABio-X Holdings, Inc., backed by CBC Group.
Company Details
- Employees
- 10
- Address
- Needham, Ma 02459, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://mlabbiosciences.com/
- HQ
- Needham, MA
Mlab Biosciences Questions
Mlab Biosciences's website is https://mlabbiosciences.com/
Mlab Biosciences's LinkedIn profile is https://www.linkedin.com/company/mlab-biosciences
Mlab Biosciences has
10 employees.
View email and phone details for 10
employees at Mlab Biosciences.
Mlab Biosciences's industry is
Biotechnology Research
Mlab Biosciences's top competitors are
Neurocrine Biosciences,
Marengo Therapeutics,
Ensem Therapeutics,
Intellia Therapeutics, Inc.,
Leadermed Health Group Limited,
I-Mab Biopharma,
Rvac Medicines,
Abio-X,
Canbridge Pharmaceuticals Inc.,
Seismic Therapeutic.
Mlab Biosciences's categories are Biotechnology Research
